We found that the high-risk group was significantly associated with higher expression level of immune checkpoints and immune inhibitory factors, including CCL2, CTLA4, CXCR4, IL6, LAG3, PDCD1, and TGFB1, indicating tumor immune evasion (Figure 7J). This evidence concerns the gene PDCD1 and neoplasm.